NFKB1 and renal carcinoma: In the present study, we showed that the treatment of human renal cancer cells with cordycepin inhibited TNF-α-mediated NF-κB/GADD45B signaling, which upregulated the MKK7-JNK signaling pathway activation through inhibition of c-FLIPL expression.